Identification of the Novel HLA‐G*01:63 Allele by PolyseqOne and Oxford Nanopore Sequencing Technology
HLA · 2026-01 · 107 (1)
DOI: 10.1111/tan.70532 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, online erschienen am 25.12.2025. Verfasst von Yuzi Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Blood Transfusion, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China. Hauptthemen laut MEDLINE: Exons, HLA-G Antigens. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 3 Literaturangaben. Gefördert von: Science and Technology Projects in Guangzhou, the Key Medical Disciplines and Specialties Program of Guangzhou (2025-2027).
Abstract (Originalsprache)
HLA‐G*01:63 differs from HLA‐G*01:01:01:01 by a single nonsynonymous nucleotide substitution in codon 259 of exon 4.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Blood Transfusion, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China.
- DAFEI Biotechnology, Guangzhou, China.
- Institute of Blood Transfusion and Hematology, Guangzhou Blood Center, Guangzhou Medical University, Guangzhou, China.
- The Key Medical Laboratory of Guangzhou, Guangzhou, China.
Förderung
- Science and Technology Projects in Guangzhou
- the Key Medical Disciplines and Specialties Program of Guangzhou (2025-2027)
Zitieren
APA
Chen, Y., He, R., & Wen, J. (2026). Identification of the Novel HLA‐G*01:63 Allele by PolyseqOne and Oxford Nanopore Sequencing Technology. HLA, 107(1). https://doi.org/10.1111/tan.70532
Vancouver
Chen Y, He R, Wen J. Identification of the Novel HLA‐G*01:63 Allele by PolyseqOne and Oxford Nanopore Sequencing Technology. HLA. 2026;107(1). doi:10.1111/tan.70532
BibTeX
@article{Chen2026,
author = {Chen, Yuzi and He, Runjun and Wen, Jizhi},
title = {Identification of the Novel HLA‐G*01:63 Allele by PolyseqOne and Oxford Nanopore Sequencing Technology},
journal = {HLA},
year = {2026},
volume = {107},
number = {1},
doi = {10.1111/tan.70532}
}
EUVIMED